{"primaryid":85315284,"caseid":8531528,"pt":"Pallor","caseversion":4,"i_f_code":"F","event_dt":"2012-03-22","mfr_dt":"2012-09-15","init_fda_dt":"2012-04-26","fda_dt":"2012-09-27","rept_cod":"EXP","mfr_num":"JP-SANOFI-AVENTIS-2012SA028706","mfr_sndr":"AVENTIS","age":70,"age_YR":70,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-09-27","to_mfr":"","occp_cod":"MD","reporter_country":"JP","occr_country":"JP","patient_drug":[{"primaryid":85315284,"caseid":8531528,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"TAKEN TO:AROUND 22 MAR 12","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2009-06-18","end_dt":"2012-03-22","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2009-06-18"}
{"primaryid":85315284,"caseid":8531528,"pt":"Sulphaemoglobin increased","caseversion":4,"i_f_code":"F","event_dt":"2012-03-22","mfr_dt":"2012-09-15","init_fda_dt":"2012-04-26","fda_dt":"2012-09-27","rept_cod":"EXP","mfr_num":"JP-SANOFI-AVENTIS-2012SA028706","mfr_sndr":"AVENTIS","age":70,"age_YR":70,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-09-27","to_mfr":"","occp_cod":"MD","reporter_country":"JP","occr_country":"JP","patient_drug":[{"primaryid":85315284,"caseid":8531528,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"TAKEN TO:AROUND 22 MAR 12","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2009-06-18","end_dt":"2012-03-22","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2009-06-18"}
{"primaryid":87568591,"caseid":8756859,"pt":"Death","caseversion":1,"i_f_code":"I","event_dt":"2012-06-15","mfr_dt":"2012-08-23","init_fda_dt":"2012-08-28","fda_dt":"2012-08-28","rept_cod":"EXP","mfr_num":"CA-SANOFI-AVENTIS-2012SA061029","mfr_sndr":"AVENTIS","age":48,"age_YR":48,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-08-28","to_mfr":"","occp_cod":"PH","reporter_country":"CA","occr_country":"CA","patient_drug":[{"primaryid":87568591,"caseid":8756859,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-09-15","end_dt":"2012-06-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2010-09-15"}
{"primaryid":88286211,"caseid":8828621,"pt":"Amyotrophic lateral sclerosis","caseversion":1,"i_f_code":"I","mfr_dt":"2012-09-05","init_fda_dt":"2012-10-05","fda_dt":"2012-10-05","rept_cod":"EXP","mfr_num":"KH-SANOFI-AVENTIS-2012SA073220","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-05","to_mfr":"","occp_cod":"CN","reporter_country":"KH","occr_country":"TH","patient_drug":[{"primaryid":88286211,"caseid":8828621,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":88286211,"caseid":8828621,"pt":"Aphagia","caseversion":1,"i_f_code":"I","mfr_dt":"2012-09-05","init_fda_dt":"2012-10-05","fda_dt":"2012-10-05","rept_cod":"EXP","mfr_num":"KH-SANOFI-AVENTIS-2012SA073220","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-05","to_mfr":"","occp_cod":"CN","reporter_country":"KH","occr_country":"TH","patient_drug":[{"primaryid":88286211,"caseid":8828621,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":88286211,"caseid":8828621,"pt":"Asthenia","caseversion":1,"i_f_code":"I","mfr_dt":"2012-09-05","init_fda_dt":"2012-10-05","fda_dt":"2012-10-05","rept_cod":"EXP","mfr_num":"KH-SANOFI-AVENTIS-2012SA073220","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-05","to_mfr":"","occp_cod":"CN","reporter_country":"KH","occr_country":"TH","patient_drug":[{"primaryid":88286211,"caseid":8828621,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":88286211,"caseid":8828621,"pt":"Choking","caseversion":1,"i_f_code":"I","mfr_dt":"2012-09-05","init_fda_dt":"2012-10-05","fda_dt":"2012-10-05","rept_cod":"EXP","mfr_num":"KH-SANOFI-AVENTIS-2012SA073220","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-05","to_mfr":"","occp_cod":"CN","reporter_country":"KH","occr_country":"TH","patient_drug":[{"primaryid":88286211,"caseid":8828621,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":88286211,"caseid":8828621,"pt":"Drug ineffective","caseversion":1,"i_f_code":"I","mfr_dt":"2012-09-05","init_fda_dt":"2012-10-05","fda_dt":"2012-10-05","rept_cod":"EXP","mfr_num":"KH-SANOFI-AVENTIS-2012SA073220","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-05","to_mfr":"","occp_cod":"CN","reporter_country":"KH","occr_country":"TH","patient_drug":[{"primaryid":88286211,"caseid":8828621,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":88286211,"caseid":8828621,"pt":"Dyspnoea","caseversion":1,"i_f_code":"I","mfr_dt":"2012-09-05","init_fda_dt":"2012-10-05","fda_dt":"2012-10-05","rept_cod":"EXP","mfr_num":"KH-SANOFI-AVENTIS-2012SA073220","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-05","to_mfr":"","occp_cod":"CN","reporter_country":"KH","occr_country":"TH","patient_drug":[{"primaryid":88286211,"caseid":8828621,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":88408631,"caseid":8840863,"pt":"Death","caseversion":1,"i_f_code":"I","mfr_dt":"2012-10-02","init_fda_dt":"2012-10-15","fda_dt":"2012-10-15","rept_cod":"EXP","mfr_num":"US-SANOFI-AVENTIS-2012SA072756","mfr_sndr":"AVENTIS","age":64,"age_YR":64,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt_cod":"","rept_dt":"2012-10-15","to_mfr":"","occp_cod":"MD","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":88408631,"caseid":8840863,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"UNKNOWN","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":89264171,"caseid":8926417,"pt":"Dizziness","caseversion":1,"i_f_code":"I","event_dt":"2010-06-30","mfr_dt":"2012-11-21","init_fda_dt":"2012-11-26","fda_dt":"2012-11-26","rept_cod":"EXP","mfr_num":"DE-SANOFI-AVENTIS-2012SA068705","mfr_sndr":"AVENTIS","age":63,"age_YR":63,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":48,"wt_cod":"KG","rept_dt":"2012-11-26","to_mfr":"","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":89264171,"caseid":8926417,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"U","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2004-07-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"1","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2004-07-15"}
{"primaryid":89264171,"caseid":8926417,"pt":"Drug interaction","caseversion":1,"i_f_code":"I","event_dt":"2010-06-30","mfr_dt":"2012-11-21","init_fda_dt":"2012-11-26","fda_dt":"2012-11-26","rept_cod":"EXP","mfr_num":"DE-SANOFI-AVENTIS-2012SA068705","mfr_sndr":"AVENTIS","age":63,"age_YR":63,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":48,"wt_cod":"KG","rept_dt":"2012-11-26","to_mfr":"","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":89264171,"caseid":8926417,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"U","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2004-07-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"1","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2004-07-15"}
{"primaryid":89264171,"caseid":8926417,"pt":"General physical health deterioration","caseversion":1,"i_f_code":"I","event_dt":"2010-06-30","mfr_dt":"2012-11-21","init_fda_dt":"2012-11-26","fda_dt":"2012-11-26","rept_cod":"EXP","mfr_num":"DE-SANOFI-AVENTIS-2012SA068705","mfr_sndr":"AVENTIS","age":63,"age_YR":63,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":48,"wt_cod":"KG","rept_dt":"2012-11-26","to_mfr":"","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":89264171,"caseid":8926417,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"U","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2004-07-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"1","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2004-07-15"}
{"primaryid":89283582,"caseid":8928358,"pt":"Death","caseversion":2,"i_f_code":"F","event_dt":"2012-11-03","mfr_dt":"2012-12-10","init_fda_dt":"2012-11-28","fda_dt":"2012-12-14","rept_cod":"EXP","mfr_num":"US-SANOFI-AVENTIS-2012SA084852","mfr_sndr":"AVENTIS","age":79,"age_YR":79,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt_cod":"","rept_dt":"2012-12-14","to_mfr":"","occp_cod":"MD","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":89283582,"caseid":8928358,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNKNOWN","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"Q12H","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2012-11-03","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":89344341,"caseid":8934434,"pt":"Agranulocytosis","caseversion":1,"i_f_code":"I","event_dt":"2012-08-30","mfr_dt":"2012-11-21","init_fda_dt":"2012-11-29","fda_dt":"2012-11-29","rept_cod":"EXP","mfr_num":"FR-SANOFI-AVENTIS-2012SA085610","mfr_sndr":"AVENTIS","age":86,"age_YR":86,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt_cod":"","rept_dt":"2012-11-29","to_mfr":"","occp_cod":"OT","reporter_country":"FR","occr_country":"FR","patient_drug":[{"primaryid":89344341,"caseid":8934434,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"UNK","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"BID","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-05-03","end_dt":"2012-08-31","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-05-03"}
{"primaryid":89727641,"caseid":8972764,"pt":"Venous thrombosis","caseversion":1,"i_f_code":"I","event_dt":"2012-09-25","mfr_dt":"2012-12-13","init_fda_dt":"2012-12-18","fda_dt":"2012-12-18","rept_cod":"EXP","mfr_num":"SE-ROCHE-1168735","mfr_sndr":"ROCHE","age":59,"age_YR":59,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-12-18","to_mfr":"","occp_cod":"MD","reporter_country":"SE","occr_country":"SE","patient_drug":[{"primaryid":89727641,"caseid":8972764,"drug_seq":1,"role_cod":"PS","drugname":"Copegus","val_vbm":1,"route":"ORAL","dose_vbm":"1 GMD","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"","nda_num":"021511","dose_amt":"","dose_unit":"","dose_form":"Film-coated tablet","dose_freq":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-09-11","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"Copegus","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"Copegus","start_dt_ps":"2012-09-11"}
{"primaryid":89727961,"caseid":8972796,"pt":"Venous thrombosis","caseversion":1,"i_f_code":"I","event_dt":"2012-04-17","mfr_dt":"2012-12-13","init_fda_dt":"2012-12-18","fda_dt":"2012-12-18","rept_cod":"EXP","mfr_num":"SE-ROCHE-1168736","mfr_sndr":"ROCHE","age":61,"age_YR":61,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2012-12-18","to_mfr":"","occp_cod":"MD","reporter_country":"SE","occr_country":"SE","patient_drug":[{"primaryid":89727961,"caseid":8972796,"drug_seq":1,"role_cod":"PS","drugname":"Copegus","val_vbm":1,"route":"ORAL","dose_vbm":"1 GMD","cum_dose_unit":"","dechal":"","rechal":"D","lot_nbr":"","nda_num":"021511","dose_amt":"","dose_unit":"","dose_form":"Film-coated tablet","dose_freq":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2011-11-10","end_dt":"2012-02-23","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"Copegus","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"Copegus","start_dt_ps":"2011-11-10"}
{"primaryid":89838092,"caseid":8983809,"pt":"Venous thrombosis limb","caseversion":2,"i_f_code":"F","event_dt":"2011-04-13","mfr_dt":"2013-01-15","init_fda_dt":"2012-12-24","fda_dt":"2013-01-16","rept_cod":"EXP","mfr_num":"SE-ROCHE-1168737","mfr_sndr":"ROCHE","age":39,"age_YR":39,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt_cod":"","rept_dt":"2013-01-16","to_mfr":"","occp_cod":"MD","reporter_country":"SE","occr_country":"SE","patient_drug":[{"primaryid":89838092,"caseid":8983809,"drug_seq":1,"role_cod":"PS","drugname":"Copegus","val_vbm":1,"route":"ORAL","dose_vbm":"DOSE REGIMEN: 1GMD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"21511","dose_amt":"200","dose_unit":"MG","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2011-01-31","end_dt":"2012-02-14","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"Copegus","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"Copegus","start_dt_ps":"2011-01-31"}
{"primaryid":91081651,"caseid":9108165,"pt":"Urinary retention","caseversion":1,"i_f_code":"I","mfr_dt":"2013-02-15","init_fda_dt":"2013-02-21","fda_dt":"2013-02-21","rept_cod":"EXP","mfr_num":"JP-SANOFI-AVENTIS-2013SA015595","mfr_sndr":"AVENTIS","age_cod":"","gndr_cod":"F","e_sub":"Y","wt_cod":"","rept_dt":"2013-02-21","to_mfr":"","occp_cod":"PH","reporter_country":"JP","occr_country":"JP","patient_drug":[{"primaryid":91081651,"caseid":9108165,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"UNKNOWN","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":91650761,"caseid":9165076,"pt":"Death","caseversion":1,"i_f_code":"I","mfr_dt":"2013-03-11","init_fda_dt":"2013-03-15","fda_dt":"2013-03-15","rept_cod":"EXP","mfr_num":"US-SANOFI-AVENTIS-2013SA024870","mfr_sndr":"AVENTIS","age":74,"age_YR":74,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt_cod":"","rept_dt":"2013-03-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":91650761,"caseid":9165076,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"UNKNOWN","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":92541111,"caseid":9254111,"pt":"Drug effect decreased","caseversion":1,"i_f_code":"I","event_dt":"2013-02-09","init_fda_dt":"2013-04-22","fda_dt":"2013-04-22","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":66.5,"wt_cod":"KG","rept_dt":"2013-03-25","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92541111,"caseid":9254111,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"N","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-07","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN","start_dt_ps":"2013-01-07"}
{"primaryid":92541111,"caseid":9254111,"pt":"Hypotonia","caseversion":1,"i_f_code":"I","event_dt":"2013-02-09","init_fda_dt":"2013-04-22","fda_dt":"2013-04-22","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":66.5,"wt_cod":"KG","rept_dt":"2013-03-25","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92541111,"caseid":9254111,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"N","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-07","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN","start_dt_ps":"2013-01-07"}
{"primaryid":92541111,"caseid":9254111,"pt":"Muscle spasms","caseversion":1,"i_f_code":"I","event_dt":"2013-02-09","init_fda_dt":"2013-04-22","fda_dt":"2013-04-22","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":66.5,"wt_cod":"KG","rept_dt":"2013-03-25","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92541111,"caseid":9254111,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"N","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-07","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN","start_dt_ps":"2013-01-07"}
{"primaryid":92541111,"caseid":9254111,"pt":"Respiratory depression","caseversion":1,"i_f_code":"I","event_dt":"2013-02-09","init_fda_dt":"2013-04-22","fda_dt":"2013-04-22","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":66.5,"wt_cod":"KG","rept_dt":"2013-03-25","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92541111,"caseid":9254111,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"N","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-07","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN","start_dt_ps":"2013-01-07"}
{"primaryid":92541111,"caseid":9254111,"pt":"Sedation","caseversion":1,"i_f_code":"I","event_dt":"2013-02-09","init_fda_dt":"2013-04-22","fda_dt":"2013-04-22","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":66.5,"wt_cod":"KG","rept_dt":"2013-03-25","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92541111,"caseid":9254111,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"N","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-07","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN","start_dt_ps":"2013-01-07"}
{"primaryid":92541111,"caseid":9254111,"pt":"Toxicity to various agents","caseversion":1,"i_f_code":"I","event_dt":"2013-02-09","init_fda_dt":"2013-04-22","fda_dt":"2013-04-22","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":66.5,"wt_cod":"KG","rept_dt":"2013-03-25","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92541111,"caseid":9254111,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"N","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-07","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN","start_dt_ps":"2013-01-07"}
{"primaryid":92783241,"caseid":9278324,"pt":"Forearm fracture","caseversion":1,"i_f_code":"I","event_dt":"2013-01-19","mfr_dt":"2013-04-29","init_fda_dt":"2013-05-08","fda_dt":"2013-05-08","rept_cod":"EXP","mfr_num":"KR-SANOFI-AVENTIS-2013SA044204","mfr_sndr":"AVENTIS","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":46.6,"wt_cod":"KG","rept_dt":"2013-05-08","to_mfr":"","occp_cod":"MD","reporter_country":"KR","occr_country":"KR","patient_drug":[{"primaryid":92783241,"caseid":9278324,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"UNKNOWN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-10-08","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2012-10-08"}
{"primaryid":92784071,"caseid":9278407,"pt":"Gastrostomy","caseversion":1,"i_f_code":"I","event_dt":"2012-10-08","mfr_dt":"2013-04-29","init_fda_dt":"2013-05-08","fda_dt":"2013-05-08","rept_cod":"EXP","mfr_num":"KR-SANOFI-AVENTIS-2013SA044211","mfr_sndr":"AVENTIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":44.6,"wt_cod":"KG","rept_dt":"2013-05-08","to_mfr":"","occp_cod":"MD","reporter_country":"KR","occr_country":"KR","patient_drug":[{"primaryid":92784071,"caseid":9278407,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"QD","lot_num":"UNKNOWN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-08-31","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2012-08-31"}
{"primaryid":92805841,"caseid":9280584,"pt":"Gastrostomy","caseversion":1,"i_f_code":"I","event_dt":"2012-11-15","mfr_dt":"2013-04-29","init_fda_dt":"2013-05-09","fda_dt":"2013-05-09","rept_cod":"EXP","mfr_num":"KR-SANOFI-AVENTIS-2013SA044215","mfr_sndr":"AVENTIS","age":78,"age_YR":78,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":48,"wt_cod":"KG","rept_dt":"2013-05-09","to_mfr":"","occp_cod":"MD","reporter_country":"KR","occr_country":"KR","patient_drug":[{"primaryid":92805841,"caseid":9280584,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"FILM-COATED TABLET","dose_freq":"","lot_num":"UNKNOWN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-10-27","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2012-10-27"}
{"primaryid":92836621,"caseid":9283662,"pt":"Respiratory disorder","caseversion":1,"i_f_code":"I","event_dt":"2013-02-22","mfr_dt":"2013-04-26","init_fda_dt":"2013-05-08","fda_dt":"2013-05-08","rept_cod":"EXP","mfr_num":"2013P1005333","mfr_sndr":"COVIS","age":59,"age_YR":59,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":155,"wt_cod":"LBS","rept_dt":"2013-05-03","to_mfr":"","occp_cod":"MD","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92836621,"caseid":9283662,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG; BID; PO","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-07-15","end_dt":"2013-02-21","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-07-15"}
{"primaryid":92967163,"caseid":9296716,"pt":"Alanine aminotransferase increased","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Alkalosis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Anaemia","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Aspartate aminotransferase increased","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Atelectasis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Blood pressure decreased","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Blood urea increased","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Bronchial secretion retention","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Carbon dioxide increased","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Chronic hepatitis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Dehydration","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Depression","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Drug hypersensitivity","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Gastric dilatation","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Hypertension","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Hypokalaemia","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Liver function test abnormal","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Lung disorder","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Pneumonia","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Renal function test abnormal","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Respiratory depression","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Sedation","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":92967163,"caseid":9296716,"pt":"Tachycardia","caseversion":3,"i_f_code":"F","event_dt":"2013-03-06","mfr_dt":"2013-06-04","init_fda_dt":"2013-05-15","fda_dt":"2013-06-21","rept_cod":"EXP","mfr_num":"2013P1005525","mfr_sndr":"COVIS","age":55,"age_YR":55,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":157,"wt_cod":"LBS","rept_dt":"2013-06-19","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":92967163,"caseid":9296716,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","exp_dt":"2015-04-15","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"8063653","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-06","end_dt":"2013-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-06"}
{"primaryid":93173281,"caseid":9317328,"pt":"Drug ineffective","caseversion":1,"i_f_code":"I","mfr_dt":"2013-02-20","init_fda_dt":"2013-05-24","fda_dt":"2013-05-24","rept_cod":"EXP","mfr_num":"2013P1006407","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","gndr_cod":"F","e_sub":"N","wt_cod":"","rept_dt":"2013-05-23","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93173281,"caseid":9317328,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-02-01","end_dt":"2013-03-27","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"1","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-02-01"}
{"primaryid":93173281,"caseid":9317328,"pt":"Dysphagia","caseversion":1,"i_f_code":"I","mfr_dt":"2013-02-20","init_fda_dt":"2013-05-24","fda_dt":"2013-05-24","rept_cod":"EXP","mfr_num":"2013P1006407","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","gndr_cod":"F","e_sub":"N","wt_cod":"","rept_dt":"2013-05-23","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93173281,"caseid":9317328,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-02-01","end_dt":"2013-03-27","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"1","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-02-01"}
{"primaryid":93173281,"caseid":9317328,"pt":"General physical health deterioration","caseversion":1,"i_f_code":"I","mfr_dt":"2013-02-20","init_fda_dt":"2013-05-24","fda_dt":"2013-05-24","rept_cod":"EXP","mfr_num":"2013P1006407","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","gndr_cod":"F","e_sub":"N","wt_cod":"","rept_dt":"2013-05-23","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93173281,"caseid":9317328,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-02-01","end_dt":"2013-03-27","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"1","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-02-01"}
{"primaryid":93642282,"caseid":9364228,"pt":"Haemorrhagic stroke","caseversion":2,"i_f_code":"F","event_dt":"2013-05-27","mfr_dt":"2013-06-10","init_fda_dt":"2013-06-19","fda_dt":"2013-06-25","rept_cod":"EXP","mfr_num":"2013P1008343","mfr_sndr":"COVIS","age":83,"age_YR":83,"age_cod":"YR","gndr_cod":"F","e_sub":"N","wt_cod":"","rept_dt":"2013-06-21","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93642282,"caseid":9364228,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"GASTROSTOMY TUBE","dose_vbm":"","cum_dose_unit":"","dechal":"N","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-05-25","end_dt":"2013-05-25","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"0","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-05-25"}
{"primaryid":93806513,"caseid":9380651,"pt":"Amyotrophic lateral sclerosis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Cerebral atrophy","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Cerebral disorder","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Cerebral ventricle dilatation","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Concussion","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Condition aggravated","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Contusion","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Diplopia","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Dizziness","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Drug ineffective","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Dyspnoea","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Ecchymosis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Excoriation","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Eye disorder","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Eye movement disorder","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Eye swelling","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Face injury","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Facial pain","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Fall","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Finger deformity","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Headache","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Joint injury","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Laceration","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Local swelling","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Muscular weakness","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Musculoskeletal chest pain","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Musculoskeletal pain","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Osteoarthritis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Periorbital haematoma","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Skeletal injury","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Spinal osteoarthritis","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":93806513,"caseid":9380651,"pt":"Upper limb fracture","caseversion":3,"i_f_code":"F","event_dt":"2013-03-17","mfr_dt":"2013-07-08","init_fda_dt":"2013-06-28","fda_dt":"2013-07-17","rept_cod":"EXP","mfr_num":"2013P1010031","mfr_sndr":"COVIS","age":69,"age_YR":69,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":180,"wt_cod":"LBS","rept_dt":"2013-07-15","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":93806513,"caseid":9380651,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"100","dose_unit":"MG","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-17","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-03-17"}
{"primaryid":94168101,"caseid":9416810,"pt":"Cognitive disorder","caseversion":1,"i_f_code":"I","event_dt":"2012-06-30","mfr_dt":"2013-07-10","init_fda_dt":"2013-07-19","fda_dt":"2013-07-19","rept_cod":"EXP","mfr_num":"2013P1012111","mfr_sndr":"COVIS","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":165,"wt_cod":"LBS","rept_dt":"2013-07-17","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":94168101,"caseid":9416810,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-06-30","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-06-30"}
{"primaryid":94168101,"caseid":9416810,"pt":"Neuropathy peripheral","caseversion":1,"i_f_code":"I","event_dt":"2012-06-30","mfr_dt":"2013-07-10","init_fda_dt":"2013-07-19","fda_dt":"2013-07-19","rept_cod":"EXP","mfr_num":"2013P1012111","mfr_sndr":"COVIS","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":165,"wt_cod":"LBS","rept_dt":"2013-07-17","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":94168101,"caseid":9416810,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-06-30","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-06-30"}
{"primaryid":94168101,"caseid":9416810,"pt":"Therapeutic response unexpected","caseversion":1,"i_f_code":"I","event_dt":"2012-06-30","mfr_dt":"2013-07-10","init_fda_dt":"2013-07-19","fda_dt":"2013-07-19","rept_cod":"EXP","mfr_num":"2013P1012111","mfr_sndr":"COVIS","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":165,"wt_cod":"LBS","rept_dt":"2013-07-17","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":94168101,"caseid":9416810,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-06-30","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-06-30"}
{"primaryid":94168101,"caseid":9416810,"pt":"Thinking abnormal","caseversion":1,"i_f_code":"I","event_dt":"2012-06-30","mfr_dt":"2013-07-10","init_fda_dt":"2013-07-19","fda_dt":"2013-07-19","rept_cod":"EXP","mfr_num":"2013P1012111","mfr_sndr":"COVIS","age":58,"age_YR":58,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt":165,"wt_cod":"LBS","rept_dt":"2013-07-17","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":94168101,"caseid":9416810,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-06-30","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-06-30"}
{"primaryid":95592431,"caseid":9559243,"pt":"Pulmonary oedema","caseversion":1,"i_f_code":"I","mfr_dt":"2013-09-25","init_fda_dt":"2013-09-27","fda_dt":"2013-09-27","rept_cod":"EXP","mfr_num":"PHEH2013US020142","mfr_sndr":"NOVARTIS","age_cod":"","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2013-09-27","to_mfr":"","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","patient_drug":[{"primaryid":95592431,"caseid":9559243,"drug_seq":1,"role_cod":"PS","drugname":"TOBI","val_vbm":1,"route":"","dose_vbm":"300 MG, BID","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"50753","dose_amt":"300","dose_unit":"MG","dose_form":"SOL. AEROSOL METERED DOSE INH.","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TOBI","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TOBI"}
{"primaryid":94656312,"caseid":9465631,"pt":"Crying","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Drug dose omission","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Insomnia","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Nausea","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Product adhesion issue","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Product quality issue","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Pruritus","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Somnolence","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":94656312,"caseid":9465631,"pt":"Wrong technique in drug usage process","caseversion":2,"i_f_code":"F","event_dt":"2013-07-13","mfr_dt":"2013-10-21","init_fda_dt":"2013-08-20","fda_dt":"2013-11-04","rept_cod":"EXP","mfr_num":"CO-JNJFOC-20130806278","mfr_sndr":"JANSSEN","age":31,"age_YR":31,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":97,"wt_cod":"KG","rept_dt":"2013-11-04","to_mfr":"","occp_cod":"CN","reporter_country":"CO","occr_country":"CO","patient_drug":[{"primaryid":94656312,"caseid":9465631,"drug_seq":1,"role_cod":"PS","drugname":"DUROGESIC","val_vbm":1,"route":"TRANSDERMAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"N","nda_num":"19813","dose_amt":"","dose_unit":"","dose_form":"UNSPECIFIED","dose_freq":"","lot_num":"CKB3Y00;DBB2N00","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-07-13","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"DUROGESIC","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"DUROGESIC","start_dt_ps":"2013-07-13"}
{"primaryid":96246992,"caseid":9624699,"pt":"Autoimmune haemolytic anaemia","caseversion":2,"i_f_code":"F","mfr_dt":"2013-10-22","init_fda_dt":"2013-10-10","fda_dt":"2013-11-08","rept_cod":"EXP","mfr_num":"2013P1019993","mfr_sndr":"COVIS","age":79,"age_YR":79,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-11-05","to_mfr":"","occp_cod":"MD","reporter_country":"JP","occr_country":"","patient_drug":[{"primaryid":96246992,"caseid":9624699,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"N","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-12-15","end_dt":"2013-09-17","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2010-12-15"}
{"primaryid":96246992,"caseid":9624699,"pt":"Blood pressure increased","caseversion":2,"i_f_code":"F","mfr_dt":"2013-10-22","init_fda_dt":"2013-10-10","fda_dt":"2013-11-08","rept_cod":"EXP","mfr_num":"2013P1019993","mfr_sndr":"COVIS","age":79,"age_YR":79,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-11-05","to_mfr":"","occp_cod":"MD","reporter_country":"JP","occr_country":"","patient_drug":[{"primaryid":96246992,"caseid":9624699,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"N","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-12-15","end_dt":"2013-09-17","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2010-12-15"}
{"primaryid":96246992,"caseid":9624699,"pt":"Tachycardia","caseversion":2,"i_f_code":"F","mfr_dt":"2013-10-22","init_fda_dt":"2013-10-10","fda_dt":"2013-11-08","rept_cod":"EXP","mfr_num":"2013P1019993","mfr_sndr":"COVIS","age":79,"age_YR":79,"age_cod":"YR","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-11-05","to_mfr":"","occp_cod":"MD","reporter_country":"JP","occr_country":"","patient_drug":[{"primaryid":96246992,"caseid":9624699,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"N","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-12-15","end_dt":"2013-09-17","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2010-12-15"}
{"primaryid":96393443,"caseid":9639344,"pt":"Amyotrophic lateral sclerosis","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96393443,"caseid":9639344,"pt":"Asphyxia","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96393443,"caseid":9639344,"pt":"Cardiac arrest","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96393443,"caseid":9639344,"pt":"Disease progression","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96393443,"caseid":9639344,"pt":"Muscular weakness","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96393443,"caseid":9639344,"pt":"PO2 decreased","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96393443,"caseid":9639344,"pt":"Pneumonia aspiration","caseversion":3,"i_f_code":"F","mfr_dt":"2013-10-10","init_fda_dt":"2013-10-21","fda_dt":"2013-10-24","rept_cod":"EXP","mfr_num":"ADR-2013-01871","mfr_sndr":"MEDTRONIC","age_cod":"","gndr_cod":"M","e_sub":"N","wt_cod":"","rept_dt":"2013-10-22","to_mfr":"","occp_cod":"OT","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"","patient_drug":[{"primaryid":96393443,"caseid":9639344,"drug_seq":1,"role_cod":"PS","drugname":"GABALON INTRATHECAL","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20075","dose_amt":"65/28","dose_unit":"MCG","dose_form":"","dose_freq":"QD","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"1","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GABALON INTRATHECAL","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GABALON INTRATHECAL"}
{"primaryid":96745421,"caseid":9674542,"pt":"Rash","caseversion":1,"i_f_code":"I","init_fda_dt":"2013-11-05","fda_dt":"2013-11-05","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age_cod":"","gndr_cod":"M","e_sub":"N","wt":236,"wt_cod":"LBS","to_mfr":"","occp_cod":"PH","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":96745421,"caseid":9674542,"drug_seq":1,"role_cod":"PS","drugname":"EXJADE","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"D","exp_dt":"2016-04-30","dose_amt":"2500","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"FO196","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-08-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"EXJADE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"EXJADE","start_dt_ps":"2013-08-15"}
{"primaryid":97091091,"caseid":9709109,"pt":"Allergic respiratory symptom","caseversion":1,"i_f_code":"I","event_dt":"2010-12-15","mfr_dt":"2013-11-11","init_fda_dt":"2013-11-25","fda_dt":"2013-11-25","rept_cod":"EXP","mfr_num":"US-ACORDA-ACO_100403_2013","mfr_sndr":"ACORDA","age":85,"age_YR":85,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":74.83,"wt_cod":"KG","rept_dt":"2013-11-25","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":97091091,"caseid":9709109,"drug_seq":1,"role_cod":"PS","drugname":"Zanaflex","val_vbm":1,"route":"ORAL","dose_vbm":"TIZANIDINE UNK","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20397","dose_amt":"","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"Zanaflex","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"Zanaflex"}
{"primaryid":97091091,"caseid":9709109,"pt":"Gastrointestinal bacterial infection","caseversion":1,"i_f_code":"I","event_dt":"2010-12-15","mfr_dt":"2013-11-11","init_fda_dt":"2013-11-25","fda_dt":"2013-11-25","rept_cod":"EXP","mfr_num":"US-ACORDA-ACO_100403_2013","mfr_sndr":"ACORDA","age":85,"age_YR":85,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":74.83,"wt_cod":"KG","rept_dt":"2013-11-25","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":97091091,"caseid":9709109,"drug_seq":1,"role_cod":"PS","drugname":"Zanaflex","val_vbm":1,"route":"ORAL","dose_vbm":"TIZANIDINE UNK","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20397","dose_amt":"","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"Zanaflex","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"Zanaflex"}
{"primaryid":97091091,"caseid":9709109,"pt":"Unresponsive to stimuli","caseversion":1,"i_f_code":"I","event_dt":"2010-12-15","mfr_dt":"2013-11-11","init_fda_dt":"2013-11-25","fda_dt":"2013-11-25","rept_cod":"EXP","mfr_num":"US-ACORDA-ACO_100403_2013","mfr_sndr":"ACORDA","age":85,"age_YR":85,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":74.83,"wt_cod":"KG","rept_dt":"2013-11-25","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":97091091,"caseid":9709109,"drug_seq":1,"role_cod":"PS","drugname":"Zanaflex","val_vbm":1,"route":"ORAL","dose_vbm":"TIZANIDINE UNK","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20397","dose_amt":"","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2012-06-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"Zanaflex","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"Zanaflex"}
{"primaryid":97680061,"caseid":9768006,"pt":"Cardiac arrest","caseversion":1,"i_f_code":"I","event_dt":"2012-01-30","mfr_dt":"2012-09-21","init_fda_dt":"2013-12-17","fda_dt":"2013-12-17","rept_cod":"PER","mfr_num":"2012BAX018014","mfr_sndr":"BAXTER","age":65,"age_YR":65,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":80,"wt_cod":"KG","rept_dt":"2013-06-20","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"","patient_drug":[{"primaryid":97680061,"caseid":9768006,"drug_seq":1,"role_cod":"PS","drugname":"GAMMAGARD LIQUID (IMMUNOGLOBULIN, NORMAL HUMAN) (SOLUTION FOR INFUSI","val_vbm":1,"route":"","dose_vbm":"(1 IN 1 M) , INTRAVENOUS?","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"125105","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"UNKNOWN?","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GAMMAGARD LIQUID (IMMUNOGLOBULIN, NORMAL HUMAN) (SOLUTION FOR INFUSI","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GAMMAGARD LIQUID (IMMUNOGLOBULIN, NORMAL HUMAN) (SOLUTION FOR INFUSI"}
{"primaryid":100131171,"caseid":10013117,"pt":"Cardiac arrest","caseversion":1,"i_f_code":"I","event_dt":"2012-01-30","mfr_dt":"2012-09-21","init_fda_dt":"2014-03-14","fda_dt":"2014-03-14","rept_cod":"EXP","mfr_num":"US-BAXTER-2012BAX018014","mfr_sndr":"BAXTER","age":65,"age_YR":65,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt":79.55,"wt_cod":"KG","rept_dt":"2014-03-14","to_mfr":"N","occp_cod":"CN","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":100131171,"caseid":10013117,"drug_seq":1,"role_cod":"PS","drugname":"GAMMAGARD LIQUID","val_vbm":1,"route":"INTRAVENOUS","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"13591","dose_amt":"","dose_unit":"","dose_form":"SOLUTION FOR INFUSION","dose_freq":"/month","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-06-30","end_dt":"2011-06-30","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GAMMAGARD LIQUID","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GAMMAGARD LIQUID","start_dt_ps":"2010-06-30"}
{"primaryid":98719182,"caseid":9871918,"pt":"Dry mouth","caseversion":2,"i_f_code":"F","event_dt":"2013-03-11","mfr_dt":"2013-06-07","init_fda_dt":"2014-02-05","fda_dt":"2014-02-05","rept_cod":"PER","mfr_num":"US-ALLERGAN-1305453US","mfr_sndr":"ALLERGAN","age":83,"age_YR":83,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2014-02-05","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":98719182,"caseid":9871918,"drug_seq":1,"role_cod":"PS","drugname":"BOTOX","val_vbm":1,"route":"INTRAMUSCULAR","dose_vbm":"50 UNITS, SINGLE","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103000","dose_amt":"","dose_unit":"","dose_form":"POWDER FOR INJECTION","dose_freq":"QD","lot_num":"C3173","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-11","end_dt":"2013-03-11","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BOTOX","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BOTOX","start_dt_ps":"2013-03-11"}
{"primaryid":98719182,"caseid":9871918,"pt":"Off label use","caseversion":2,"i_f_code":"F","event_dt":"2013-03-11","mfr_dt":"2013-06-07","init_fda_dt":"2014-02-05","fda_dt":"2014-02-05","rept_cod":"PER","mfr_num":"US-ALLERGAN-1305453US","mfr_sndr":"ALLERGAN","age":83,"age_YR":83,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2014-02-05","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","patient_drug":[{"primaryid":98719182,"caseid":9871918,"drug_seq":1,"role_cod":"PS","drugname":"BOTOX","val_vbm":1,"route":"INTRAMUSCULAR","dose_vbm":"50 UNITS, SINGLE","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103000","dose_amt":"","dose_unit":"","dose_form":"POWDER FOR INJECTION","dose_freq":"QD","lot_num":"C3173","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-03-11","end_dt":"2013-03-11","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BOTOX","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BOTOX","start_dt_ps":"2013-03-11"}
{"primaryid":99882551,"caseid":9988255,"pt":"Abdominal distension","caseversion":1,"i_f_code":"I","event_dt":"2013-12-17","mfr_dt":"2014-02-24","init_fda_dt":"2014-03-10","fda_dt":"2014-03-10","rept_cod":"EXP","mfr_num":"DE-MYLANLABS-2014S1004247","mfr_sndr":"MYLAN","age":72,"age_YR":72,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":60,"wt_cod":"KG","rept_dt":"2014-03-09","to_mfr":"N","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":99882551,"caseid":9988255,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"DAILY DOSE: 100 MG MILLGRAM(S) EVERY DAYS","cum_dose_chr":4700,"cum_dose_unit":"MG","dechal":"","rechal":"D","nda_num":"203042","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-11-15","end_dt":"2014-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2013-11-15"}
{"primaryid":99882551,"caseid":9988255,"pt":"Abdominal pain upper","caseversion":1,"i_f_code":"I","event_dt":"2013-12-17","mfr_dt":"2014-02-24","init_fda_dt":"2014-03-10","fda_dt":"2014-03-10","rept_cod":"EXP","mfr_num":"DE-MYLANLABS-2014S1004247","mfr_sndr":"MYLAN","age":72,"age_YR":72,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":60,"wt_cod":"KG","rept_dt":"2014-03-09","to_mfr":"N","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":99882551,"caseid":9988255,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"DAILY DOSE: 100 MG MILLGRAM(S) EVERY DAYS","cum_dose_chr":4700,"cum_dose_unit":"MG","dechal":"","rechal":"D","nda_num":"203042","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-11-15","end_dt":"2014-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2013-11-15"}
{"primaryid":99882551,"caseid":9988255,"pt":"Anorectal varices haemorrhage","caseversion":1,"i_f_code":"I","event_dt":"2013-12-17","mfr_dt":"2014-02-24","init_fda_dt":"2014-03-10","fda_dt":"2014-03-10","rept_cod":"EXP","mfr_num":"DE-MYLANLABS-2014S1004247","mfr_sndr":"MYLAN","age":72,"age_YR":72,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":60,"wt_cod":"KG","rept_dt":"2014-03-09","to_mfr":"N","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":99882551,"caseid":9988255,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"DAILY DOSE: 100 MG MILLGRAM(S) EVERY DAYS","cum_dose_chr":4700,"cum_dose_unit":"MG","dechal":"","rechal":"D","nda_num":"203042","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-11-15","end_dt":"2014-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2013-11-15"}
{"primaryid":99882551,"caseid":9988255,"pt":"Diarrhoea","caseversion":1,"i_f_code":"I","event_dt":"2013-12-17","mfr_dt":"2014-02-24","init_fda_dt":"2014-03-10","fda_dt":"2014-03-10","rept_cod":"EXP","mfr_num":"DE-MYLANLABS-2014S1004247","mfr_sndr":"MYLAN","age":72,"age_YR":72,"age_cod":"YR","gndr_cod":"F","e_sub":"Y","wt":60,"wt_cod":"KG","rept_dt":"2014-03-09","to_mfr":"N","occp_cod":"MD","reporter_country":"DE","occr_country":"DE","patient_drug":[{"primaryid":99882551,"caseid":9988255,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE","val_vbm":1,"route":"ORAL","dose_vbm":"DAILY DOSE: 100 MG MILLGRAM(S) EVERY DAYS","cum_dose_chr":4700,"cum_dose_unit":"MG","dechal":"","rechal":"D","nda_num":"203042","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-11-15","end_dt":"2014-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE","start_dt_ps":"2013-11-15"}
{"primaryid":99355792,"caseid":9935579,"pt":"Respiratory failure","caseversion":2,"i_f_code":"F","mfr_dt":"2014-04-04","init_fda_dt":"2014-02-28","fda_dt":"2014-04-11","rept_cod":"EXP","mfr_num":"JP-BAXTER-2014BAX008876","mfr_sndr":"BAXTER","age":57,"age_YR":57,"age_cod":"YR","gndr_cod":"M","e_sub":"Y","wt_cod":"","rept_dt":"2014-04-11","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"JP","patient_drug":[{"primaryid":99355792,"caseid":9935579,"drug_seq":1,"role_cod":"PS","drugname":"GAMMAGARD FOR INJECTION 2.5G","val_vbm":1,"route":"INTRAVENOUS","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103133","dose_amt":"","dose_unit":"","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INFUSION","dose_freq":"","lot_num":"","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GAMMAGARD FOR INJECTION 2.5G","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GAMMAGARD FOR INJECTION 2.5G"}
{"primaryid":103709701,"caseid":10370970,"pt":"Asthenia","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2014-08-05","init_fda_dt":"2014-08-07","fda_dt":"2014-08-07","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":64,"age_YR":64,"age_cod":"YR","e_sub":"N","wt":63,"wt_cod":"KG","rept_dt":"2014-08-06","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":103709701,"caseid":10370970,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"1 TABLET, BID, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2","dur_cod":"DAY"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":103709701,"caseid":10370970,"pt":"Dyspnoea","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2014-08-05","init_fda_dt":"2014-08-07","fda_dt":"2014-08-07","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":64,"age_YR":64,"age_cod":"YR","e_sub":"N","wt":63,"wt_cod":"KG","rept_dt":"2014-08-06","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":103709701,"caseid":10370970,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"1 TABLET, BID, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2","dur_cod":"DAY"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":103709701,"caseid":10370970,"pt":"Lung disorder","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2014-08-05","init_fda_dt":"2014-08-07","fda_dt":"2014-08-07","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":64,"age_YR":64,"age_cod":"YR","e_sub":"N","wt":63,"wt_cod":"KG","rept_dt":"2014-08-06","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":103709701,"caseid":10370970,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"1 TABLET, BID, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2","dur_cod":"DAY"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":103709701,"caseid":10370970,"pt":"Mental status changes","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2014-08-05","init_fda_dt":"2014-08-07","fda_dt":"2014-08-07","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":64,"age_YR":64,"age_cod":"YR","e_sub":"N","wt":63,"wt_cod":"KG","rept_dt":"2014-08-06","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":103709701,"caseid":10370970,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"1 TABLET, BID, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2","dur_cod":"DAY"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":104725931,"caseid":10472593,"pt":"Atrial fibrillation","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2014-09-08","init_fda_dt":"2014-09-23","fda_dt":"2014-09-23","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":71,"age_YR":71,"age_cod":"YR","e_sub":"N","wt":85.7,"wt_cod":"KG","rept_dt":"2014-09-22","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":104725931,"caseid":10472593,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"D","nda_num":"","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-07-28","end_dt":"2014-09-08","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2014-07-28"}
{"primaryid":104725931,"caseid":10472593,"pt":"Tachycardia","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2014-09-08","init_fda_dt":"2014-09-23","fda_dt":"2014-09-23","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":71,"age_YR":71,"age_cod":"YR","e_sub":"N","wt":85.7,"wt_cod":"KG","rept_dt":"2014-09-22","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":104725931,"caseid":10472593,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"D","nda_num":"","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-07-28","end_dt":"2014-09-08","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2014-07-28"}
{"primaryid":105619472,"caseid":10561947,"pt":"Death","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-09-07","mfr_dt":"2014-11-24","init_fda_dt":"2014-11-04","fda_dt":"2014-12-04","rept_cod":"EXP","mfr_num":"US-BEH-2014045947","mfr_sndr":"CSL BEHRING","age":60,"age_YR":60,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2014-12-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":105619472,"caseid":10561947,"drug_seq":1,"role_cod":"PS","drugname":"PRIVIGEN","val_vbm":1,"route":"","dose_vbm":"5GM/VIAL;300 TO 600 MG/KG INFUSION EVERY 3-4 WEEKS","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"125201","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"HUMAN IMMUNOGLOBULIN G","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-07-02","end_dt":"2014-07-09","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"PRIVIGEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"PRIVIGEN","start_dt_ps":"2014-07-02"}
{"primaryid":105690581,"caseid":10569058,"pt":"Aspiration","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2014-10-29","init_fda_dt":"2014-11-06","fda_dt":"2014-11-06","rept_cod":"EXP","mfr_num":"PHEH2014US021953","mfr_sndr":"NOVARTIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2014-11-06","to_mfr":"N","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":105690581,"caseid":10569058,"drug_seq":1,"role_cod":"PS","drugname":"TOBI","val_vbm":1,"route":"INHALATION","dose_vbm":"300 MG, BID","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"050753","dose_amt":"300","dose_unit":"MG","dose_form":"SOL. AEROSOL METERED DOSE INH.","dose_freq":"BID","lot_num":"F5069","prod_ai":"TOBRAMYCIN","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TOBI","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TOBI"}
{"primaryid":105690581,"caseid":10569058,"pt":"Excessive granulation tissue","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2014-10-29","init_fda_dt":"2014-11-06","fda_dt":"2014-11-06","rept_cod":"EXP","mfr_num":"PHEH2014US021953","mfr_sndr":"NOVARTIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2014-11-06","to_mfr":"N","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":105690581,"caseid":10569058,"drug_seq":1,"role_cod":"PS","drugname":"TOBI","val_vbm":1,"route":"INHALATION","dose_vbm":"300 MG, BID","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"050753","dose_amt":"300","dose_unit":"MG","dose_form":"SOL. AEROSOL METERED DOSE INH.","dose_freq":"BID","lot_num":"F5069","prod_ai":"TOBRAMYCIN","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TOBI","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TOBI"}
{"primaryid":105690581,"caseid":10569058,"pt":"Haemorrhage","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2014-10-29","init_fda_dt":"2014-11-06","fda_dt":"2014-11-06","rept_cod":"EXP","mfr_num":"PHEH2014US021953","mfr_sndr":"NOVARTIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2014-11-06","to_mfr":"N","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":105690581,"caseid":10569058,"drug_seq":1,"role_cod":"PS","drugname":"TOBI","val_vbm":1,"route":"INHALATION","dose_vbm":"300 MG, BID","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"050753","dose_amt":"300","dose_unit":"MG","dose_form":"SOL. AEROSOL METERED DOSE INH.","dose_freq":"BID","lot_num":"F5069","prod_ai":"TOBRAMYCIN","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TOBI","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TOBI"}
{"primaryid":104383103,"caseid":10438310,"pt":"Off label use","drug_rec_act":"","caseversion":3,"i_f_code":"F","mfr_dt":"2015-01-29","init_fda_dt":"2014-09-08","fda_dt":"2015-01-30","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-A1087514A","mfr_sndr":"GLAXOSMITHKLINE","age":68,"age_YR":68,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-01-30","to_mfr":"N","occp_cod":"CN","reporter_country":"GB","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":104383103,"caseid":10438310,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"022345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":104383103,"caseid":10438310,"pt":"Urinary retention","drug_rec_act":"","caseversion":3,"i_f_code":"F","mfr_dt":"2015-01-29","init_fda_dt":"2014-09-08","fda_dt":"2015-01-30","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-A1087514A","mfr_sndr":"GLAXOSMITHKLINE","age":68,"age_YR":68,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-01-30","to_mfr":"N","occp_cod":"CN","reporter_country":"GB","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":104383103,"caseid":10438310,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"022345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":104383103,"caseid":10438310,"pt":"Wrong technique in drug usage process","drug_rec_act":"","caseversion":3,"i_f_code":"F","mfr_dt":"2015-01-29","init_fda_dt":"2014-09-08","fda_dt":"2015-01-30","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-A1087514A","mfr_sndr":"GLAXOSMITHKLINE","age":68,"age_YR":68,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-01-30","to_mfr":"N","occp_cod":"CN","reporter_country":"GB","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":104383103,"caseid":10438310,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"022345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":107473781,"caseid":10747378,"pt":"Death","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-01-26","init_fda_dt":"2015-01-28","fda_dt":"2015-01-28","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":56,"age_YR":56,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-01-27","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107473781,"caseid":10747378,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","exp_dt":"2016-04-30","nda_num":"","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"02141441","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-09-10","end_dt":"2015-01-26","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2014-09-10"}
{"primaryid":108224022,"caseid":10822402,"pt":"Acute respiratory distress syndrome","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Arrhythmia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Asthenia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Cardiac arrest","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Disseminated intravascular coagulation","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Drug eruption","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Dysstasia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Eczema nummular","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Multi-organ failure","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Pneumonia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Pyrexia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Renal failure","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Respiratory failure","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108224022,"caseid":10822402,"pt":"Speech disorder","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-12-18","mfr_dt":"2015-02-23","init_fda_dt":"2015-02-13","fda_dt":"2015-03-10","rept_cod":"EXP","mfr_num":"2015COV00029","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-03-06","to_mfr":"N","occp_cod":"MD","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108224022,"caseid":10822402,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-12-11","end_dt":"2014-12-30","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-12-11"}
{"primaryid":108226551,"caseid":10822655,"pt":"Acute respiratory distress syndrome","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-02-02","init_fda_dt":"2015-02-13","fda_dt":"2015-02-13","rept_cod":"EXP","mfr_num":"2015COV00030","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-02-12","to_mfr":"N","occp_cod":"","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108226551,"caseid":10822655,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":108226551,"caseid":10822655,"pt":"Pneumonia","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-02-02","init_fda_dt":"2015-02-13","fda_dt":"2015-02-13","rept_cod":"EXP","mfr_num":"2015COV00030","mfr_sndr":"COVIS","age":68,"age_YR":68,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-02-12","to_mfr":"N","occp_cod":"","reporter_country":"JP","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":108226551,"caseid":10822655,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":109241801,"caseid":10924180,"pt":"Amyotrophic lateral sclerosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2013-12-27","init_fda_dt":"2015-02-05","fda_dt":"2015-02-05","rept_cod":"PER","mfr_num":"2013P1022369","mfr_sndr":"COVIS","age":74,"age_YR":74,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2014-12-16","to_mfr":"N","occp_cod":"CN","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":109241801,"caseid":10924180,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020599","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"0","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":109646761,"caseid":10964676,"pt":"Bone loss","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-01-22","mfr_dt":"2015-02-18","init_fda_dt":"2015-03-29","fda_dt":"2015-03-29","rept_cod":"PER","mfr_num":"US-CELGENEUS-USA-2015024113","mfr_sndr":"CELGENE","age":56,"age_YR":56,"age_cod":"YR","e_sub":"Y","wt":68,"wt_cod":"KG","rept_dt":"2015-03-29","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":109646761,"caseid":10964676,"drug_seq":1,"role_cod":"PS","drugname":"THALOMID","val_vbm":1,"route":"ORAL","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"020785","dose_amt":"50","dose_unit":"MG","dose_form":"CAPSULES","dose_freq":"QD","lot_num":"B0013BE","prod_ai":"THALIDOMIDE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2011-12-15","end_dt":"2013-06-30","dur":"","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"THALOMID","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"THALOMID","start_dt_ps":"2011-12-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Abasia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Erythema","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Fatigue","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Injection site reaction","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Liquid product physical issue","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Product use issue","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":107906522,"caseid":10790652,"pt":"Pyrexia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2014-02-03","mfr_dt":"2015-04-02","init_fda_dt":"2015-02-12","fda_dt":"2015-04-10","rept_cod":"EXP","mfr_num":"BR-BAYER-2015-017807","mfr_sndr":"BAYER","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-04-07","to_mfr":"N","occp_cod":"CN","reporter_country":"BR","occr_country":"BR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":107906522,"caseid":10790652,"drug_seq":1,"role_cod":"PS","drugname":"BETAFERON","val_vbm":1,"route":"Subcutaneous","dose_vbm":"DOSE OF ALL AMPOULE, QOD","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"103471","dose_amt":"1","dose_unit":"DF","dose_form":"POWDER AND SOLVENT FOR SOLUTION FOR INJECTION","dose_freq":"QOD","lot_num":"34022A","prod_ai":"INTERFERON BETA-1B","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2010-03-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BETAFERON","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BETAFERON","start_dt_ps":"2010-03-15"}
{"primaryid":110245731,"caseid":11024573,"pt":"Death","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-04-01","init_fda_dt":"2015-04-13","fda_dt":"2015-04-13","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":59,"age_YR":59,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-04-10","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110245731,"caseid":11024573,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","exp_dt":"2016-06-30","nda_num":"","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"02142264","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-08-29","end_dt":"2015-04-01","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2013-08-29"}
{"primaryid":110308891,"caseid":11030889,"pt":"Respiratory arrest","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-15","mfr_dt":"2015-04-01","init_fda_dt":"2015-04-13","fda_dt":"2015-04-13","rept_cod":"EXP","mfr_num":"2015COV00077","mfr_sndr":"COVIS","age_cod":"","e_sub":"N","wt_cod":"","rept_dt":"2015-04-10","to_mfr":"N","occp_cod":"CN","reporter_country":"CO","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110308891,"caseid":11030889,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY, ORAL","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-03-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"0","report_source_CSM":"1","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"1","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-03-15"}
{"primaryid":110666801,"caseid":11066680,"pt":"Amyotrophic lateral sclerosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2013-05-09","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1005836","mfr_sndr":"COVIS","age":49,"age_YR":49,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110666801,"caseid":11066680,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","exp_dt":"2014-01-02","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"Q12H","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-01-08","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"0","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-01-08"}
{"primaryid":110666941,"caseid":11066694,"pt":"Abdominal discomfort","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2013-03-15","mfr_dt":"2013-03-14","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1006553","mfr_sndr":"COVIS","age":80,"age_YR":80,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":110666941,"caseid":11066694,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"500707810","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2.5","dur_cod":"WK"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":110666941,"caseid":11066694,"pt":"Death","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2013-03-15","mfr_dt":"2013-03-14","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1006553","mfr_sndr":"COVIS","age":80,"age_YR":80,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":110666941,"caseid":11066694,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"500707810","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2.5","dur_cod":"WK"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":110666941,"caseid":11066694,"pt":"Malaise","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2013-03-15","mfr_dt":"2013-03-14","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1006553","mfr_sndr":"COVIS","age":80,"age_YR":80,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":110666941,"caseid":11066694,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"500707810","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","dur":"2.5","dur_cod":"WK"}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":110666951,"caseid":11066695,"pt":"Amyotrophic lateral sclerosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2013-06-30","mfr_dt":"2013-07-11","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1012339","mfr_sndr":"COVIS","age":73,"age_YR":73,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"CN","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":110666951,"caseid":11066695,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-06-26","end_dt":"2013-06-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"1","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2012-06-26"}
{"primaryid":110666991,"caseid":11066699,"pt":"Disease progression","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2013-12-06","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1021866","mfr_sndr":"COVIS","age_cod":"","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":110666991,"caseid":11066699,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020599","dose_amt":"","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":110666991,"caseid":11066699,"pt":"Dysphagia","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2013-12-06","init_fda_dt":"2015-04-16","fda_dt":"2015-04-16","rept_cod":"PER","mfr_num":"2013P1021866","mfr_sndr":"COVIS","age_cod":"","e_sub":"N","wt_cod":"","rept_dt":"2014-01-07","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":110666991,"caseid":11066699,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020599","dose_amt":"","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":110997711,"caseid":11099771,"pt":"Activities of daily living impaired","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Amyotrophic lateral sclerosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Anxiety","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Condition aggravated","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Depressed mood","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Disease progression","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Dysarthria","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Fatigue","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Gait disturbance","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Muscle atrophy","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Muscle contractions involuntary","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Muscle spasms","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Muscle spasticity","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Myalgia","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Tearfulness","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":110997711,"caseid":11099771,"pt":"Thermal burn","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-04-20","init_fda_dt":"2015-05-06","fda_dt":"2015-05-06","rept_cod":"EXP","mfr_num":"ADR-2015-00884","mfr_sndr":"MEDTRONIC","age":57,"age_YR":57,"age_cod":"YR","e_sub":"N","wt_cod":"","rept_dt":"2015-05-05","to_mfr":"N","occp_cod":"MD","reporter_country":"PL","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":110997711,"caseid":11099771,"drug_seq":1,"role_cod":"PS","drugname":"BACLOFEN.","val_vbm":1,"route":"","dose_vbm":"10MG/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"020075","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"BACLOFEN","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2012-01-15","dur":"","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"1","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"BACLOFEN.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"BACLOFEN.","start_dt_ps":"2012-01-15"}
{"primaryid":112304871,"caseid":11230487,"pt":"Dehydration","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-06-16","init_fda_dt":"2015-06-29","fda_dt":"2015-06-29","rept_cod":"EXP","mfr_num":"2015COV00131","mfr_sndr":"COVIS","age_cod":"","e_sub":"N","wt_cod":"","rept_dt":"2015-06-26","to_mfr":"N","occp_cod":"CN","reporter_country":"CA","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112304871,"caseid":11230487,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"D","rechal":"D","nda_num":"020599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2014-10-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","report_source_HP":"0","report_source_CSM":"1","report_source_FGN":"1","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2014-10-15"}
{"primaryid":111183452,"caseid":11118345,"pt":"Chest pain","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-05-04","mfr_dt":"2015-05-08","init_fda_dt":"2015-05-18","fda_dt":"2015-09-03","rept_cod":"EXP","mfr_num":"IT-TEVA-562303ACC","mfr_sndr":"TEVA","age":57,"age_YR":57,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-09-03","to_mfr":"N","occp_cod":"MD","reporter_country":"IT","occr_country":"IT","auth_num":"IT-MINISAL02-307140","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":111183452,"caseid":11118345,"drug_seq":1,"role_cod":"PS","drugname":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","val_vbm":1,"route":"Intravenous (not otherwise specified)","dose_vbm":"355 UG CYCLICAL","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"125294","dose_amt":"355","dose_unit":"UG","dose_form":"SOLUTION FOR INFUSION","dose_freq":"","lot_num":"","prod_ai":"FILGRASTIM","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-05-04","end_dt":"2015-05-04","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","start_dt_ps":"2015-05-04"}
{"primaryid":111183452,"caseid":11118345,"pt":"Dyspnoea","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-05-04","mfr_dt":"2015-05-08","init_fda_dt":"2015-05-18","fda_dt":"2015-09-03","rept_cod":"EXP","mfr_num":"IT-TEVA-562303ACC","mfr_sndr":"TEVA","age":57,"age_YR":57,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-09-03","to_mfr":"N","occp_cod":"MD","reporter_country":"IT","occr_country":"IT","auth_num":"IT-MINISAL02-307140","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":111183452,"caseid":11118345,"drug_seq":1,"role_cod":"PS","drugname":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","val_vbm":1,"route":"Intravenous (not otherwise specified)","dose_vbm":"355 UG CYCLICAL","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"125294","dose_amt":"355","dose_unit":"UG","dose_form":"SOLUTION FOR INFUSION","dose_freq":"","lot_num":"","prod_ai":"FILGRASTIM","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-05-04","end_dt":"2015-05-04","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","start_dt_ps":"2015-05-04"}
{"primaryid":111183452,"caseid":11118345,"pt":"Hypoxia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-05-04","mfr_dt":"2015-05-08","init_fda_dt":"2015-05-18","fda_dt":"2015-09-03","rept_cod":"EXP","mfr_num":"IT-TEVA-562303ACC","mfr_sndr":"TEVA","age":57,"age_YR":57,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-09-03","to_mfr":"N","occp_cod":"MD","reporter_country":"IT","occr_country":"IT","auth_num":"IT-MINISAL02-307140","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":111183452,"caseid":11118345,"drug_seq":1,"role_cod":"PS","drugname":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","val_vbm":1,"route":"Intravenous (not otherwise specified)","dose_vbm":"355 UG CYCLICAL","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"125294","dose_amt":"355","dose_unit":"UG","dose_form":"SOLUTION FOR INFUSION","dose_freq":"","lot_num":"","prod_ai":"FILGRASTIM","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-05-04","end_dt":"2015-05-04","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","start_dt_ps":"2015-05-04"}
{"primaryid":111183452,"caseid":11118345,"pt":"Renal pain","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-05-04","mfr_dt":"2015-05-08","init_fda_dt":"2015-05-18","fda_dt":"2015-09-03","rept_cod":"EXP","mfr_num":"IT-TEVA-562303ACC","mfr_sndr":"TEVA","age":57,"age_YR":57,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-09-03","to_mfr":"N","occp_cod":"MD","reporter_country":"IT","occr_country":"IT","auth_num":"IT-MINISAL02-307140","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":111183452,"caseid":11118345,"drug_seq":1,"role_cod":"PS","drugname":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","val_vbm":1,"route":"Intravenous (not otherwise specified)","dose_vbm":"355 UG CYCLICAL","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"125294","dose_amt":"355","dose_unit":"UG","dose_form":"SOLUTION FOR INFUSION","dose_freq":"","lot_num":"","prod_ai":"FILGRASTIM","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-05-04","end_dt":"2015-05-04","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"TEVAGRASTIM - 30 MUI 300 MCG/0,5ML SOLUZIONE INIETTABILE O PER INFUSIO","start_dt_ps":"2015-05-04"}
{"primaryid":113135861,"caseid":11313586,"pt":"Condition aggravated","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-07-16","init_fda_dt":"2015-07-24","fda_dt":"2015-07-24","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":54,"age_YR":54,"age_cod":"YR","e_sub":"N","wt":85.5,"wt_cod":"KG","rept_dt":"2015-07-23","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":113135861,"caseid":11313586,"drug_seq":1,"role_cod":"PS","drugname":"CITALOPRAM","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"D","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"CITALOPRAM HYDROBROMIDE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-04-20","end_dt":"2015-07-16","dur":"","dur_cod":""}],"report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CITALOPRAM","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CITALOPRAM","start_dt_ps":"2015-04-20"}
{"primaryid":113135861,"caseid":11313586,"pt":"Muscle spasticity","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-07-16","init_fda_dt":"2015-07-24","fda_dt":"2015-07-24","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":54,"age_YR":54,"age_cod":"YR","e_sub":"N","wt":85.5,"wt_cod":"KG","rept_dt":"2015-07-23","to_mfr":"N","occp_cod":"PH","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":113135861,"caseid":11313586,"drug_seq":1,"role_cod":"PS","drugname":"CITALOPRAM","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"D","dose_amt":"10","dose_unit":"MG","dose_form":"","dose_freq":"QD","lot_num":"","prod_ai":"CITALOPRAM HYDROBROMIDE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-04-20","end_dt":"2015-07-16","dur":"","dur_cod":""}],"report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CITALOPRAM","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CITALOPRAM","start_dt_ps":"2015-04-20"}
{"primaryid":113365231,"caseid":11336523,"pt":"Cerebral haemorrhage","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-07-20","init_fda_dt":"2015-08-04","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"CA-APOTEX-2015AP010895","mfr_sndr":"APOTEX","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"CN","reporter_country":"CA","occr_country":"CA","auth_num":"","lit_ref":"","age_grp":"","sex":"","patient_drug":[{"primaryid":113365231,"caseid":11336523,"drug_seq":1,"role_cod":"PS","drugname":"APO-RILUZOLE","val_vbm":1,"route":"Oral","dose_vbm":"1 DF, BID","cum_dose_unit":"","dechal":"","rechal":"U","dose_amt":"1","dose_unit":"DF","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"APO-RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"APO-RILUZOLE"}
{"primaryid":113365231,"caseid":11336523,"pt":"Fall","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-07-20","init_fda_dt":"2015-08-04","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"CA-APOTEX-2015AP010895","mfr_sndr":"APOTEX","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"CN","reporter_country":"CA","occr_country":"CA","auth_num":"","lit_ref":"","age_grp":"","sex":"","patient_drug":[{"primaryid":113365231,"caseid":11336523,"drug_seq":1,"role_cod":"PS","drugname":"APO-RILUZOLE","val_vbm":1,"route":"Oral","dose_vbm":"1 DF, BID","cum_dose_unit":"","dechal":"","rechal":"U","dose_amt":"1","dose_unit":"DF","dose_form":"TABLET","dose_freq":"Q12H","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"APO-RILUZOLE","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"APO-RILUZOLE"}
{"primaryid":115803421,"caseid":11580342,"pt":"Amyotrophic lateral sclerosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-07-19","mfr_dt":"2015-09-23","init_fda_dt":"2015-09-30","fda_dt":"2015-09-30","rept_cod":"EXP","mfr_num":"CA-COVIS PHARMA S.A.R.L.-2015COV00138","mfr_sndr":"COVIS","age":61,"age_YR":61,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-09-25","to_mfr":"N","occp_cod":"CN","reporter_country":"FR","occr_country":"CA","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":115803421,"caseid":11580342,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-12-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-12-15"}
{"primaryid":115803421,"caseid":11580342,"pt":"Respiratory failure","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-07-19","mfr_dt":"2015-09-23","init_fda_dt":"2015-09-30","fda_dt":"2015-09-30","rept_cod":"EXP","mfr_num":"CA-COVIS PHARMA S.A.R.L.-2015COV00138","mfr_sndr":"COVIS","age":61,"age_YR":61,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-09-25","to_mfr":"N","occp_cod":"CN","reporter_country":"FR","occr_country":"CA","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":115803421,"caseid":11580342,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2013-12-15","dur":"","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2013-12-15"}
{"primaryid":92880046,"caseid":9288004,"pt":"Alanine aminotransferase abnormal","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Aspartate aminotransferase abnormal","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Cerebral ischaemia","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Cholecystitis","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Cholelithiasis","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Clostridium difficile colitis","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Device related infection","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Diarrhoea","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Dyspnoea","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Embolism","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Hot flush","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Neutropenia","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Pancreatitis","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Pneumonia","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Pruritus","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Pseudomembranous colitis","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Pulmonary oedema","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Sinus disorder","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Subarachnoid haemorrhage","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Sudden death","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Thrombosis","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":92880046,"caseid":9288004,"pt":"Thrombosis in device","drug_rec_act":"","caseversion":6,"i_f_code":"F","mfr_dt":"2015-07-28","init_fda_dt":"2013-05-14","fda_dt":"2015-08-04","rept_cod":"EXP","mfr_num":"US-ROCHE-1221463","mfr_sndr":"ROCHE","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-08-04","to_mfr":"N","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":", GUGLER R, LAMMERT F, LAUFS U, MUSTCHLER E, SCHMIDTKO A AND UNGER C. AMYOTROPHIC LATERAL SCLEROSIS: CEFTRIAXONE IS NOT EFFECTIVE AS A NEUROPROTECTIVE APPROACH IN A PHASE III STUDY. ARZNEIMITTELTHERAPIE 2015 MAY 01;33 (5):165-.","age_grp":"","sex":"","patient_drug":[{"primaryid":92880046,"caseid":9288004,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"D","nda_num":"63239","dose_amt":"","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"1","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":112553682,"caseid":11255368,"pt":"Dyspnoea","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":112553682,"caseid":11255368,"pt":"Endotracheal intubation","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":112553682,"caseid":11255368,"pt":"Off label use","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":112553682,"caseid":11255368,"pt":"Pneumonia aspiration","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":112553682,"caseid":11255368,"pt":"Respiratory failure","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":112553682,"caseid":11255368,"pt":"Upper airway obstruction","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":112553682,"caseid":11255368,"pt":"Wrong technique in product usage process","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2015-06-25","mfr_dt":"2015-10-06","init_fda_dt":"2015-07-09","fda_dt":"2015-10-08","rept_cod":"EXP","mfr_num":"US-GLAXOSMITHKLINE-US2015097889","mfr_sndr":"GLAXOSMITHKLINE","age":67,"age_YR":67,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":112553682,"caseid":11255368,"drug_seq":1,"role_cod":"PS","drugname":"POTIGA","val_vbm":1,"route":"Oral","dose_vbm":"200 MG, TID","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"22345","dose_amt":"200","dose_unit":"MG","dose_form":"TABLET","dose_freq":"TID","lot_num":"4ZP7112","prod_ai":"EZOGABINE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"1","outcome_HO":"1","outcome_LT":"1","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"POTIGA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"POTIGA"}
{"primaryid":116324371,"caseid":11632437,"pt":"Dysphagia","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-08-19","init_fda_dt":"2015-10-15","fda_dt":"2015-10-15","rept_cod":"PER","mfr_num":"DE-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK019057","mfr_sndr":"GLENMARK","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-15","to_mfr":"","occp_cod":"PH","reporter_country":"DE","occr_country":"DE","auth_num":"","lit_ref":"","age_grp":"","sex":"","patient_drug":[{"primaryid":116324371,"caseid":11632437,"drug_seq":1,"role_cod":"PS","drugname":"GLENTEK 50MG FILMTABLETTEN","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"91394","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GLENTEK 50MG FILMTABLETTEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GLENTEK 50MG FILMTABLETTEN"}
{"primaryid":116324371,"caseid":11632437,"pt":"Ocular icterus","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-08-19","init_fda_dt":"2015-10-15","fda_dt":"2015-10-15","rept_cod":"PER","mfr_num":"DE-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK019057","mfr_sndr":"GLENMARK","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-15","to_mfr":"","occp_cod":"PH","reporter_country":"DE","occr_country":"DE","auth_num":"","lit_ref":"","age_grp":"","sex":"","patient_drug":[{"primaryid":116324371,"caseid":11632437,"drug_seq":1,"role_cod":"PS","drugname":"GLENTEK 50MG FILMTABLETTEN","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"91394","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GLENTEK 50MG FILMTABLETTEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GLENTEK 50MG FILMTABLETTEN"}
{"primaryid":116324371,"caseid":11632437,"pt":"Vomiting","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-08-19","init_fda_dt":"2015-10-15","fda_dt":"2015-10-15","rept_cod":"PER","mfr_num":"DE-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK019057","mfr_sndr":"GLENMARK","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-10-15","to_mfr":"","occp_cod":"PH","reporter_country":"DE","occr_country":"DE","auth_num":"","lit_ref":"","age_grp":"","sex":"","patient_drug":[{"primaryid":116324371,"caseid":11632437,"drug_seq":1,"role_cod":"PS","drugname":"GLENTEK 50MG FILMTABLETTEN","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"91394","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"GLENTEK 50MG FILMTABLETTEN","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"GLENTEK 50MG FILMTABLETTEN"}
{"primaryid":117738921,"caseid":11773892,"pt":"Chest discomfort","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-11-09","init_fda_dt":"2015-11-24","fda_dt":"2015-11-24","rept_cod":"EXP","mfr_num":"CN-COVIS PHARMA S.A.R.L.-2015COV00149","mfr_sndr":"COVIS","age":59,"age_YR":59,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-11-23","to_mfr":"","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"CN","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":117738921,"caseid":11773892,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-02-15","end_dt":"2015-03-13","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2015-02-15"}
{"primaryid":117738921,"caseid":11773892,"pt":"Electrocardiogram abnormal","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-11-09","init_fda_dt":"2015-11-24","fda_dt":"2015-11-24","rept_cod":"EXP","mfr_num":"CN-COVIS PHARMA S.A.R.L.-2015COV00149","mfr_sndr":"COVIS","age":59,"age_YR":59,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-11-23","to_mfr":"","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"CN","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":117738921,"caseid":11773892,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-02-15","end_dt":"2015-03-13","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2015-02-15"}
{"primaryid":117738921,"caseid":11773892,"pt":"Mental disorder","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-11-09","init_fda_dt":"2015-11-24","fda_dt":"2015-11-24","rept_cod":"EXP","mfr_num":"CN-COVIS PHARMA S.A.R.L.-2015COV00149","mfr_sndr":"COVIS","age":59,"age_YR":59,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-11-23","to_mfr":"","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"CN","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":117738921,"caseid":11773892,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-02-15","end_dt":"2015-03-13","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2015-02-15"}
{"primaryid":117738921,"caseid":11773892,"pt":"Pneumonia","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-03-13","mfr_dt":"2015-11-09","init_fda_dt":"2015-11-24","fda_dt":"2015-11-24","rept_cod":"EXP","mfr_num":"CN-COVIS PHARMA S.A.R.L.-2015COV00149","mfr_sndr":"COVIS","age":59,"age_YR":59,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2015-11-23","to_mfr":"","occp_cod":"CN","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"CN","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":117738921,"caseid":11773892,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, UNK","cum_dose_unit":"","dechal":"","rechal":"","dose_amt":"50","dose_unit":"MG","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-02-15","end_dt":"2015-03-13","dur_cod":""}],"outcome_OT":"0","outcome_DE":"1","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2015-02-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Abdominal pain upper","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Atrial fibrillation","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Dehydration","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Diarrhoea","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Heart rate increased","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Nausea","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Product substitution issue","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118333451,"caseid":11833345,"pt":"Weight decreased","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2015-06-30","mfr_dt":"2015-12-03","init_fda_dt":"2015-12-14","fda_dt":"2015-12-14","rept_cod":"EXP","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00150","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-11","to_mfr":"","occp_cod":"PH","reporter_country":"COUNTRY NOT SPECIFIED","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118333451,"caseid":11833345,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"50 MG, 2X/DAY","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-03-15","end_dt":"2015-07-15","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2015-03-15"}
{"primaryid":118611471,"caseid":11861147,"pt":"Hyperhidrosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2011-06-30","mfr_dt":"2011-10-12","init_fda_dt":"2015-12-22","fda_dt":"2015-12-22","rept_cod":"PER","mfr_num":"US-AVANIR PHARMACEUTICALS, INC.-2011NUEUSA00045","mfr_sndr":"AVANIR","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-22","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118611471,"caseid":11861147,"drug_seq":1,"role_cod":"PS","drugname":"NUEDEXTA","val_vbm":1,"route":"","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"56954","dose_unit":"","dose_form":"CAPSULE","dose_freq":"","lot_num":"","prod_ai":"DEXTROMETHORPHAN HYDROBROMIDE\\QUINIDINE SULFATE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2011-06-30","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"NUEDEXTA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"NUEDEXTA","start_dt_ps":"2011-06-30"}
{"primaryid":118611471,"caseid":11861147,"pt":"Tinnitus","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2011-06-30","mfr_dt":"2011-10-12","init_fda_dt":"2015-12-22","fda_dt":"2015-12-22","rept_cod":"PER","mfr_num":"US-AVANIR PHARMACEUTICALS, INC.-2011NUEUSA00045","mfr_sndr":"AVANIR","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2015-12-22","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":118611471,"caseid":11861147,"drug_seq":1,"role_cod":"PS","drugname":"NUEDEXTA","val_vbm":1,"route":"","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"56954","dose_unit":"","dose_form":"CAPSULE","dose_freq":"","lot_num":"","prod_ai":"DEXTROMETHORPHAN HYDROBROMIDE\\QUINIDINE SULFATE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2011-06-30","dur_cod":""}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"NUEDEXTA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"NUEDEXTA","start_dt_ps":"2011-06-30"}
{"primaryid":119700721,"caseid":11970072,"pt":"Amyotrophic lateral sclerosis","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-06-04","init_fda_dt":"2016-01-28","fda_dt":"2016-01-28","rept_cod":"PER","mfr_num":"US-COVIS PHARMA S.A.R.L.-2015COV00126","mfr_sndr":"COVIS","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2016-01-08","to_mfr":"","occp_cod":"CN","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":119700721,"caseid":11970072,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":121178931,"caseid":12117893,"pt":"Seizure","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2016-02-16","init_fda_dt":"2016-02-26","fda_dt":"2016-02-26","rept_cod":"EXP","mfr_num":"IL-AVANIR PHARMACEUTICALS-2016NUEISR00891","mfr_sndr":"AVANIR","age_cod":"","e_sub":"Y","wt_cod":"","rept_dt":"2016-02-26","to_mfr":"","occp_cod":"CN","reporter_country":"IL","occr_country":"IL","auth_num":"","lit_ref":"","age_grp":"","sex":"","patient_drug":[{"primaryid":121178931,"caseid":12117893,"drug_seq":1,"role_cod":"PS","drugname":"NUEDEXTA","val_vbm":1,"route":"","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"U","dose_unit":"","dose_form":"CAPSULE","dose_freq":"","lot_num":"","prod_ai":"DEXTROMETHORPHAN HYDROBROMIDE\\QUINIDINE SULFATE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"NUEDEXTA","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"NUEDEXTA"}
{"primaryid":122400381,"caseid":12240038,"pt":"Pancreatitis acute","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-06-25","init_fda_dt":"2016-04-05","fda_dt":"2016-04-05","rept_cod":"PER","mfr_num":"US-ROCHE-1603336","mfr_sndr":"ROCHE","age":69,"age_YR":69,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-05","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"SMITH L. FAILURE OF CEFTRIAXONE FOR AMYOTROPHIC LATERAL SCLEROSIS. LANCET (LONDON, ENGLAND) 1992 AUG 08;340 (8815):379-.","age_grp":"","sex":"M","patient_drug":[{"primaryid":122400381,"caseid":12240038,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"50585","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":122400381,"caseid":12240038,"pt":"Treatment failure","drug_rec_act":"","caseversion":1,"i_f_code":"I","mfr_dt":"2015-06-25","init_fda_dt":"2016-04-05","fda_dt":"2016-04-05","rept_cod":"PER","mfr_num":"US-ROCHE-1603336","mfr_sndr":"ROCHE","age":69,"age_YR":69,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-05","to_mfr":"","occp_cod":"OT","reporter_country":"US","occr_country":"US","auth_num":"","lit_ref":"SMITH L. FAILURE OF CEFTRIAXONE FOR AMYOTROPHIC LATERAL SCLEROSIS. LANCET (LONDON, ENGLAND) 1992 AUG 08;340 (8815):379-.","age_grp":"","sex":"M","patient_drug":[{"primaryid":122400381,"caseid":12240038,"drug_seq":1,"role_cod":"PS","drugname":"CEFTRIAXONE.","val_vbm":1,"route":"Unknown","dose_vbm":"","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"50585","dose_unit":"","dose_form":"","dose_freq":"","lot_num":"","prod_ai":"CEFTRIAXONE","indi_pt":"Amyotrophic lateral sclerosis"}],"indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"CEFTRIAXONE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"CEFTRIAXONE."}
{"primaryid":122541651,"caseid":12254165,"pt":"Drug-induced liver injury","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-02-15","mfr_dt":"2016-03-31","init_fda_dt":"2016-04-11","fda_dt":"2016-04-11","rept_cod":"EXP","mfr_num":"FR-COVIS PHARMA S.A.R.L.-2016COV00008","mfr_sndr":"COVIS","age":74,"age_YR":74,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-08","to_mfr":"","occp_cod":"CN","reporter_country":"FR","occr_country":"FR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":122541651,"caseid":12254165,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2016-02-07","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":122541651,"caseid":12254165,"pt":"Fungal infection","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-02-15","mfr_dt":"2016-03-31","init_fda_dt":"2016-04-11","fda_dt":"2016-04-11","rept_cod":"EXP","mfr_num":"FR-COVIS PHARMA S.A.R.L.-2016COV00008","mfr_sndr":"COVIS","age":74,"age_YR":74,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-08","to_mfr":"","occp_cod":"CN","reporter_country":"FR","occr_country":"FR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":122541651,"caseid":12254165,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2016-02-07","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":122541651,"caseid":12254165,"pt":"Pancytopenia","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-02-15","mfr_dt":"2016-03-31","init_fda_dt":"2016-04-11","fda_dt":"2016-04-11","rept_cod":"EXP","mfr_num":"FR-COVIS PHARMA S.A.R.L.-2016COV00008","mfr_sndr":"COVIS","age":74,"age_YR":74,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-08","to_mfr":"","occp_cod":"CN","reporter_country":"FR","occr_country":"FR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":122541651,"caseid":12254165,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2016-02-07","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":122541651,"caseid":12254165,"pt":"Respiratory tract infection","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-02-15","mfr_dt":"2016-03-31","init_fda_dt":"2016-04-11","fda_dt":"2016-04-11","rept_cod":"EXP","mfr_num":"FR-COVIS PHARMA S.A.R.L.-2016COV00008","mfr_sndr":"COVIS","age":74,"age_YR":74,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-08","to_mfr":"","occp_cod":"CN","reporter_country":"FR","occr_country":"FR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":122541651,"caseid":12254165,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2016-02-07","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":122541651,"caseid":12254165,"pt":"Weight decreased","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-02-15","mfr_dt":"2016-03-31","init_fda_dt":"2016-04-11","fda_dt":"2016-04-11","rept_cod":"EXP","mfr_num":"FR-COVIS PHARMA S.A.R.L.-2016COV00008","mfr_sndr":"COVIS","age":74,"age_YR":74,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-04-08","to_mfr":"","occp_cod":"CN","reporter_country":"FR","occr_country":"FR","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":122541651,"caseid":12254165,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"UNK","cum_dose_unit":"","dechal":"","rechal":"","nda_num":"20599","dose_unit":"","dose_form":"TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","end_dt":"2016-02-07","dur_cod":""}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK"}
{"primaryid":122959211,"caseid":12295921,"pt":"Asthenia","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-04-13","init_fda_dt":"2016-04-21","fda_dt":"2016-04-21","rept_cod":"DIR","mfr_num":"","mfr_sndr":"","age":7,"age_YR":7,"age_cod":"YR","e_sub":"N","wt":171,"wt_cod":"LBS","rept_dt":"2016-04-20","to_mfr":"N","occp_cod":"MD","reporter_country":"US","occr_country":"","auth_num":"","lit_ref":"","age_grp":"","sex":"M","patient_drug":[{"primaryid":122959211,"caseid":12295921,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Oral","dose_vbm":"","cum_dose_unit":"","dechal":"Y","rechal":"D","dose_amt":"50","dose_unit":"MG","dose_form":"","dose_freq":"BID","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2016-03-10","end_dt":"2016-04-13","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"1","report_source_HP":"1","report_source_CSM":"0","report_source_FGN":"0","report_source_CR":"0","report_source_SDY":"0","report_source_LIT":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE.","start_dt_ps":"2016-03-10"}
{"primaryid":124160701,"caseid":12416070,"pt":"Abdominal discomfort","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-04-01","mfr_dt":"2016-05-04","init_fda_dt":"2016-05-30","fda_dt":"2016-05-30","rept_cod":"EXP","mfr_num":"IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-116631","mfr_sndr":"RANBAXY","age":66,"age_YR":66,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-05-30","to_mfr":"","occp_cod":"OT","reporter_country":"IT","occr_country":"IT","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":124160701,"caseid":12416070,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Unknown","dose_vbm":"2 DF DAILY","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"91417","dose_amt":"2","dose_unit":"DF","dose_form":"FILM-COATED TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE."}
{"primaryid":124160701,"caseid":12416070,"pt":"Nausea","drug_rec_act":"","caseversion":1,"i_f_code":"I","event_dt":"2016-04-01","mfr_dt":"2016-05-04","init_fda_dt":"2016-05-30","fda_dt":"2016-05-30","rept_cod":"EXP","mfr_num":"IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-116631","mfr_sndr":"RANBAXY","age":66,"age_YR":66,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-05-30","to_mfr":"","occp_cod":"OT","reporter_country":"IT","occr_country":"IT","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":124160701,"caseid":12416070,"drug_seq":1,"role_cod":"PS","drugname":"RILUZOLE.","val_vbm":1,"route":"Unknown","dose_vbm":"2 DF DAILY","cum_dose_unit":"","dechal":"","rechal":"U","nda_num":"91417","dose_amt":"2","dose_unit":"DF","dose_form":"FILM-COATED TABLET","dose_freq":"","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis"}],"outcome_OT":"1","outcome_DE":"0","outcome_DS":"0","outcome_HO":"0","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUZOLE.","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUZOLE."}
{"primaryid":125995442,"caseid":12599544,"pt":"Asthenia","drug_rec_act":"","caseversion":2,"i_f_code":"F","event_dt":"2016-07-09","mfr_dt":"2016-07-18","init_fda_dt":"2016-07-27","fda_dt":"2016-08-03","rept_cod":"EXP","mfr_num":"CA-COVIS PHARMA S.A.R.L.-2016COV00059","mfr_sndr":"COVIS","age":56,"age_YR":56,"age_cod":"YR","e_sub":"Y","wt_cod":"","rept_dt":"2016-08-03","to_mfr":"","occp_cod":"CN","reporter_country":"FR","occr_country":"CA","auth_num":"","lit_ref":"","age_grp":"","sex":"F","patient_drug":[{"primaryid":125995442,"caseid":12599544,"drug_seq":1,"role_cod":"PS","drugname":"RILUTEK","val_vbm":1,"route":"Oral","dose_vbm":"2 TABLETS, 1X/DAY","cum_dose_unit":"","dechal":"U","rechal":"U","nda_num":"20599","dose_amt":"2","dose_unit":"DF","dose_form":"TABLET","dose_freq":"QD","lot_num":"","prod_ai":"RILUZOLE","indi_pt":"Amyotrophic lateral sclerosis","start_dt":"2015-02-15","dur_cod":""}],"outcome_OT":"0","outcome_DE":"0","outcome_DS":"0","outcome_HO":"1","outcome_LT":"0","outcome_RI":"0","indi_pt_all":"Amyotrophic lateral sclerosis","drugname_all":"RILUTEK","indi_pt_ps":"Amyotrophic lateral sclerosis","drugname_ps":"RILUTEK","start_dt_ps":"2015-02-15"}